-
Please Remember: Members are only permitted to share their own experiences. Members are not qualified to give medical advice. Additionally, everyone manages their health differently. Please be respectful of other people's opinions about their own diabetes management.
-
Learn more about joining the Diabetes UK Support Forum team here: https://forum.diabetes.org.uk/boards/threads/volunteering-opportunities-why-dont-you-join-us.112862/
New Type2 Drug
- Thread starter wakman
- Start date
- Status
Steff
Little Miss Chatterbox
- Relationship to Diabetes
- Type 2
# Brand name: Victoza?
# Class: Glucagon-Like Peptide-1 (GLP-1) analogue
# For: Type 2 diabetes
# Route of Administration: once-daily injection
# Action: mimicks GLP-1, allowing secretion of insulin by beta cells. Also delays gastric emptying, and suppresses meal-related glucagon secretion.
# Manufacturer: Novo Nordisk
# Status: Approved in Europe July 3 2009. Undergoing FDA review as of July 2009.
# Source: Press release from manufacturer, Novo Nordisk's Victoza? (liraglutide) receives marketing authorisation in Europe (3 July 2009)
# Availability: To be available in the UK, Germany and Denmark in the summer of 2009, and in other European markets during the second half of 2009 and throughout 2010.
# Class: Glucagon-Like Peptide-1 (GLP-1) analogue
# For: Type 2 diabetes
# Route of Administration: once-daily injection
# Action: mimicks GLP-1, allowing secretion of insulin by beta cells. Also delays gastric emptying, and suppresses meal-related glucagon secretion.
# Manufacturer: Novo Nordisk
# Status: Approved in Europe July 3 2009. Undergoing FDA review as of July 2009.
# Source: Press release from manufacturer, Novo Nordisk's Victoza? (liraglutide) receives marketing authorisation in Europe (3 July 2009)
# Availability: To be available in the UK, Germany and Denmark in the summer of 2009, and in other European markets during the second half of 2009 and throughout 2010.
- Status